In comparison to the control group, significant up-regulation of EDN1 mRNA, EP300 mRNA MAPK3 mRNA, and TNF mRNA expression levels in NAFLD and NASH groups was observed. The gene discussed is MAPK3; the disease is metabolic dysfunction-associated steatotic liver disease.